De Souza M J, Luciano A A, Arce J C, Demers L M, Loucks A B
Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington 06030.
J Appl Physiol (1985). 1994 Mar;76(3):1302-9. doi: 10.1152/jappl.1994.76.3.1302.
To investigate mechanisms of blunted adrenocortical responsiveness to exercise and mild hypercortisolism in amenorrheic runners, adrenocorticotropic hormone [ACTH-(1-24) 0.25 mg Cortrosyn] stimulation tests were performed in the presence and absence of overnight dexamethasone (1 mg) suppression (DX and NDX condition, respectively) in six eumenorrheic sedentary women (ES), nine eumenorrheic runners (ER), and nine amenorrheic runners (AR). Before the NDX stimulation test, plasma cortisol was higher (P < 0.001) in AR than in ER and ES. The cortisol response to the NDX stimulation test was blunted (P < 0.001) in AR but reached similar (P > 0.7) peak levels in all groups. Dexamethasone suppressed (P < 0.001) cortisol to similar (P > 0.5) levels (approximately 20 nmol/l) in all groups. In AR, cortisol responses to the DX test were larger (P < 0.03) than to the NDX test and similar (P > 0.6) in the three groups, again reaching comparable (P > 0.8) peak levels. The blunted cortisol response to stimulation in AR in the presence of their mild hypercortisolism appears to be due to a normal limitation in maximal adrenal secretory capacity. Extrapituitary modulators of adrenal responsiveness to ACTH may explain the mild hypercortisolism observed in AR, but limitations of these tests prevent a central negative-feedback defect or an intrinsic adrenal abnormality from being excluded until results of additional studies with even lower doses of dexamethasone and submaximal doses of ACTH-(1-24) are available.
为了探究闭经跑步运动员肾上腺皮质对运动反应迟钝及轻度皮质醇增多症的机制,对6名月经正常的久坐女性(ES)、9名月经正常的跑步运动员(ER)和9名闭经跑步运动员(AR),分别在过夜地塞米松(1 mg)抑制(分别为DX和NDX条件)存在和不存在的情况下进行促肾上腺皮质激素[ACTH-(1-24) 0.25 mg可的松]刺激试验。在NDX刺激试验前,AR组的血浆皮质醇高于ER组和ES组(P < 0.001)。AR组对NDX刺激试验的皮质醇反应迟钝(P < 0.001),但所有组达到相似的(P > 0.7)峰值水平。地塞米松在所有组中将皮质醇抑制(P < 0.001)至相似的(P > 0.5)水平(约20 nmol/l)。在AR组中,DX试验的皮质醇反应大于NDX试验(P < 0.03),且三组相似(P > 0.6),再次达到可比的(P > 0.8)峰值水平。AR组在存在轻度皮质醇增多症的情况下对刺激的皮质醇反应迟钝似乎是由于肾上腺最大分泌能力的正常限制。肾上腺对ACTH反应的垂体外调节因子可能解释了AR组中观察到的轻度皮质醇增多症,但这些试验的局限性使得在获得更低剂量地塞米松和次最大剂量ACTH-(1-24)的额外研究结果之前,无法排除中枢负反馈缺陷或肾上腺内在异常。